Does the primary site really matter? Profiling mucinous ovarian cancers of uncertain primary origin (MO-CUP) to personalise treatment and inform the design of clinical trialsNicola S. Meagher, Michael Friedländer, Klaus Schuster et al.|Gynecologic Oncology|2018Cited by 19
Molecular Profiling-Selected Therapy for Treatment of Advanced Pancreaticobiliary Cancer: A Retrospective Multicenter StudyRon Epelbaum, Ravit Geva, Baruch Brenner et al.|BioMed Research International|2015Cited by 10